Solid lipid nanoparticles surface modified with anti-Contactin-2 or anti-Neurofascin for brain-targeted delivery of medicines

References

• Keegan BM, Noseworthy JH. Multiple sclerosis. Ann Rev Med 2002;53:285–302.
   PubMed Web of Science ®Google Scholar
• Stadelmann C. Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications. Curr Opin Neurol 2011;24:224–229.
   PubMed Web of Science ®Google Scholar
• Crielaard BJ, Lammers T, Schiffelers RM, Storm G. Drug targeting systems for inflammatory disease: one for all, all for one. J Control Release 2012;161:225–234.
   PubMed Web of Science ®Google Scholar
• Lanteri N, Rolandi R, Cavatorta P, et al. Myelin basic protein–lipid complex: an atomic force microscopy study. Colloids Surf A Physicochem Eng Aspects 2000;175:3–9.
   Web of Science ®Google Scholar
• Derfuss T, Parikh K, Velhin S, et al. Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. Proc Natl Acad Sci USA 2009;106:8302–8307.
   PubMed Web of Science ®Google Scholar
• Mathey E, Derfuss T, Storch M, et al. Neurofascin as a novel target for autoantibody-mediated axonal injury. J Exp Med 2007;204:2363–2372.
   PubMed Web of Science ®Google Scholar
• Boronat A, Sepúlveda M, Llufriu S, et al. Analysis of antibodies to surface epitopes of contactin-2 in multiple sclerosis. J Neuroimmunol 2012;244:103–106.
   PubMed Web of Science ®Google Scholar
• Begley DJ. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol Ther 2004;104:29–45.
   PubMed Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state or the art. Eur J Pharm Biopharm 2000;50:161–177.
   PubMed Web of Science ®Google Scholar
• Gasco MR. Solid lipid nanospheres from warm microemulsions. Pharm Technol Europe 1997;9:52–58.
   Google Scholar
• Yang S, Zhu J, Lu Y, et al. Body distribution of camptothecin solid lipid nanoparticles after oral administration. Pharm Res 1999a;16:751–757.
   PubMed Web of Science ®Google Scholar
• Yang SC, Lu LI, Caic Y, et al. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Release 1999b;59:299–307.
   PubMed Web of Science ®Google Scholar
• Sellebjerg F, Barnes D, Filippini G, et al. EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses. Eur J Neurol 2005;12:939–946.
   PubMed Web of Science ®Google Scholar
• Thrower B. Relapse management in multiple sclerosis. Neurologist 2009;15:1–5.
   PubMed Web of Science ®Google Scholar
• Kumari R, Uppal S. First report of supraventricular tachycardia after IV pulse methylprednisolone therapy. Rheumatol Int 2005;26:70–73.
   PubMed Web of Science ®Google Scholar
• Brusaferri F, Candelise L. Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials. J Neurol 2000;247:435–442.
   PubMed Web of Science ®Google Scholar
• Manjunath K, Venkateswarlu V. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. J Control Release 2005;107:215–228.
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 2012;64:83–101.
   Web of Science ®Google Scholar
• Kim GM, Bae YH, Jo WH. pH-induced micelle formation of poly(histidine-co-phenylalanine)-block poly(ethylene glycol) in aqueous media. Macromol Biosci 2005;5:1118–1124.
   PubMed Web of Science ®Google Scholar
• Hu FQ, Hong Y, Yuan H. Preparation and characterization of solid lipid nanoparticles containing peptide. Int J Pharm 2004;273:29–35.
   PubMed Web of Science ®Google Scholar
• Attama AA, Müller-Goymann CC. Investigation of surfacemodified solid lipid nanocontainers formulated with a heterolipid-templated homolipid. Int J Pharm 2007;334:179–189.
   PubMed Web of Science ®Google Scholar
• Govender T, Stolnik S, Garnett MC, et al. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release 1999;57:171–185.
   PubMed Web of Science ®Google Scholar
• Subedi RK, Kang KW, Choi HK. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur J Pharm Sci 2009;37:508–513.
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Hassanzadeh F, Sadeghi-Aliabadi H, et al. Synthesis of Pluronic F127-poly (methyl vinyl ether-alt-maleic acid) copolymer and production of its micelles for doxorubicin delivery in breast cancer. Chem Eng J 2014;240:133–146.
   Web of Science ®Google Scholar
• Youm I, Youan BBC. Uptake mechanism of Furosemide-loaded pegylated nanoparticles by cochlear cell lines. Hear Res 2013;304:7–19.
   PubMed Web of Science ®Google Scholar
• Cartiera MS, Johnson KM, Rajendran V, et al. The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. Biomaterials 2009;30:2790–2798.
   PubMed Web of Science ®Google Scholar
• Martins S, Tho I, Reimold I, et al. Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies. Int J Pharm 2012;439:49–62.
   PubMed Web of Science ®Google Scholar
• Lindner M, Heine S, Haastert K. Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination. Neuropathol Appl Neurobiol 2008;34:105–114.
   PubMed Web of Science ®Google Scholar
• Vila A, Gill H, McCallion O, Alonso M. Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. J Control Release 2004;98:231–244.
   PubMed Web of Science ®Google Scholar
• Tobar-Grande B, Godoy R, Bustos P, et al. Development of biodegradable methylprednisolone microparticles for treatment of articular pathology using a spray-drying technique. Int J Nanomedicine 2013;8:2065–2076.
   PubMed Web of Science ®Google Scholar
• Swartz M. The physiology of the lymphatic system. Adv Drug Deliv Rev 2001;50:3–20.
   PubMed Web of Science ®Google Scholar
• Ito T, Tsumoto K. Effects of subclass change on the structural stability of chimeric, humanized, and human antibodies under thermal stress. Prot Sci 2013;22:1542–1551.
   PubMed Web of Science ®Google Scholar
• Sun B, Ranganathan B, Feng SS. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer. Biomaterials 2008;29:475–486.
   PubMed Web of Science ®Google Scholar
• Maschke A, Becker C, Eyrich D, et al. Development of a spray congealing process for the preparation of insulin-loaded lipid microparticles and characterization thereof. Eur J Pharm Biopharm 2007;65:175–187.
   PubMed Web of Science ®Google Scholar
• Dong Y, Feng S. Poly(D,L-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials 2005;26:6068–6076.
   PubMed Web of Science ®Google Scholar
• Ling Y, Huang Y. 2008. Preparation and release efficiency of poly(lactic-co-glycolic) acid nanoparticles for drug loaded paclitaxel. In: Peng Y, ed. 7th Asian-Pacific Conference on Medical and Biological Engineering. Beijing, China.
   Google Scholar
• Win K, Feng S. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 2005;26:2713–2722.
   PubMed Web of Science ®Google Scholar
• Moore A, Basilion JP, Chiocca EA, Weissleder R. Measuring transferrin receptor gene expression by NMR imaging. Biochim Biophys Acta 1998;1402:239–249.
   PubMed Web of Science ®Google Scholar
• Weissleder R, Cheng HC, Bogdanova A, Bogdanov A. Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging 1997;7:258–263.
   PubMed Web of Science ®Google Scholar
• Storm G, Belliot SO, Daemen T, Lasic DD. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Deliv Rev 1995;17:31–48.
   Web of Science ®Google Scholar
• Mo Y, Lim LY. Preparation and in vitro anticancer activity of wheat germ agglutinin (WGA)-conjugated PLGA nanoparticles loaded with paclitaxel and isopropyl myristate. J Control Release 2005;107:30–42.
   PubMed Web of Science ®Google Scholar